Clinical Trials Logo

Contrast-induced Nephropathy clinical trials

View clinical trials related to Contrast-induced Nephropathy.

Filter by:

NCT ID: NCT00830193 Completed - Critically Ill Clinical Trials

N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography

Start date: August 2002
Phase: Phase 2/Phase 3
Study type: Interventional

Critically ill patients frequently undergo contrast enhanced computed tomography (CT) to establish diagnoses and direct management. Contrast agents can disturb kidney function and result in kidney dysfunction. The investigators investigated the effects of high dose N-acetylcysteine (NAC) or placebo, in addition to hydration, in preventing kidney dysfunction following contrast enhanced CT) in critically ill adults in the intensive care units of two teaching hospitals.

NCT ID: NCT00827788 Completed - Clinical trials for Acute Myocardial Infarction

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)

CONTRAST-AMI
Start date: December 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the incidence of contrast induced nephropathy and myocardial tissue reperfusion following iso-osmolar iodixanol or ipo-osmolar iopromide administration in patients with acute myocardial infarction undergoing primary PCI.

NCT ID: NCT00770796 Completed - Clinical trials for Contrast Induced Nephropathy

Statins for Prevention of Contrast Induced Nephropathy

Start date: April 2006
Phase: Phase 4
Study type: Interventional

In this randomized study the investigators wish to explore the role of pre-procedural statin therapy for the prevention of contrast induced nephropathy in patients with moderate-to-severe renal dysfunction, submitted to elective coronary or angioplasty.

NCT ID: NCT00770614 Completed - Clinical trials for Contrast Induced Nephropathy

Hydration and Contrast-Induced Nephropathy in Primary Angioplasty

Start date: March 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether hydration with sodium bicarbonate is more effective than hydration with sodium chloride to prevent contrast induced nephropathy in patients undergoing Primary Coronary Intervention for Acute ST Elevation Myocardial Infarction.

NCT ID: NCT00639912 Completed - Clinical trials for Contrast Induced Nephropathy

Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.

CINIMA
Start date: June 2007
Phase: Phase 4
Study type: Interventional

The aim of the study is to test the efficacy of low versus high volume hydration and two different solutions (sodium chloride versus sodium bicarbonate) in preventing contrast induced nephropathy (CIN) in ST elevation myocardial infarction (STEMI) patients undergoing primary PCI.

NCT ID: NCT00634491 Completed - Clinical trials for Contrast Induced Nephropathy

Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy

Start date: September 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is whether Acetazolamide is effective in prevention of contrast nephropathy

NCT ID: NCT00606827 Completed - Clinical trials for Contrast-Induced Nephropathy

Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy

Start date: January 2005
Phase: Phase 4
Study type: Interventional

Contrast-induced nephrophaty (CIN) accounts for more than 10% of hospital-acquired renal failure. Hydration with sodium bicarbonate is more protective than isotonic saline in animals. Limited data are available in humans. We compared the efficacy of sodium bicarbonate versus isotonic saline to prevent CIN in a large population of patients with renal dysfunction undergoing coronary angiography or intervention.

NCT ID: NCT00531765 Completed - Clinical trials for Contrast Induced Nephropathy

Sodium Bicarbonate in Preventing Contrast Induced Nephropathy

SIPCIN
Start date: June 2007
Phase: N/A
Study type: Interventional

We plan to conduct an open-label, randomized, stratified, parallel-group study to compare normal saline infusion to sodium bicarbonate infusion.

NCT ID: NCT00514150 Completed - Clinical trials for Contrast Induced Nephropathy

Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)

Start date: August 2007
Phase: Phase 3
Study type: Interventional

Radio Contrast Induced Nephropathy (RCIN) remains a well recognized complication in patients undergoing diagnostic or interventional procedures requiring radiographic contrast agents. Recent studies have shown benefit in administering Sodium Bicarbonate over normal saline( the uniformly accepted prophylaxy) in preventing RCIN.Therefore the aim of the study is to evaluate the efficacy of sodium bicarbonate solved in normal saline compared with infusion of normal saline in prevention of RCIN.

NCT ID: NCT00513825 Completed - Clinical trials for Contrast Induced Nephropathy

Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN

Start date: August 2007
Phase: Phase 2
Study type: Interventional

Radio Contrast Induced Nephropathy (RCIN) remains a well recognized complication in patients undergoing diagnostic or interventional procedures requiring radiographic contrast agents. Recent studies have shown benefit in administering Sodium Bicarbonate over normal saline( the uniformly accepted prophylaxy) in preventing RCIN.But most studies have excluded patients with history of pulmonary edema, severe heart failure(NYHA 3-4), uncontrolled hypertension or ejection fraction less than 30%. Therefore the aim of this study is to evaluate the efficacy of sodium bicarbonate solved in half saline compared with infusion of half saline in prevention of RCIN in these groups of patients.